Search
Search Results
##search.searchResults.foundPlural##
-
IMMUNOTHERAPY FOR EPSTEIN-BARR VIRUS-RELATED LYMPHOMAS
1097PDF: 580HTML: 6780 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3491PDF: 831HTML: 6693 -
-
Tacrolimus Associated Posterior Reversible Encephalopathy Syndrome – A Case Series and Review
3458PDF: 1440HTML: 4274CoverLetter: 167Figure1: 174 -
-
HEMATOLOGY PATIENT PROTECTION DURING THE COVID-19 PANDEMIC IN ITALY: A NATIONWIDE NURSING SURVEY Hematology patient protection during the COVID-19
1510PDF: 545HTML: 212 -
-
CLINICAL ASPECTS AND THERAPY OF SPORADIC BURKITT LYMPHOMA
1224PDF: 586HTML: 3051 -
TREATMENT RECOMMENDATIONS FOR CHRONIC MYELOID LEUKEMIA
3226PDF: 1425HTML: 3970 -
MINIMAL RESIDUAL DISEASE IN ACUTE MYELOID LEUKEMIA OF ADULTS: DETERMINATION, PROGNOSTIC IMPACT AND CLINICAL APPLICATIONS.
4553PDF: 1280HTML: 1884Untitled: 163Untitled: 161 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1283HTML: 362PDF: 785 -
LYMPHOPROLIFERATIVE SYNDROMES ASSOCIATED WITH HUMAN HERPESVIRUS-6A AND HUMAN HERPESVIRUS-6B
3654PDF: 1406HTML: 456Figures . Eliassian: 198 -
CANDIDA ASSOCIATED BLOODSTREAM INFECTIONS IN PEDIATRIC HEMATOLOGY PATIENTS: SINGLE CENTER EXPERIENCE
4290PDF: 866HTML: 1297Table1: 164 -
Bordetella Bronchiseptica in the Immunosuppressed Population – A Case Series and Review.
2351PDF: 1246HTML: 1714CoverLetter: 157 -
PLASMABLASTIC LYMPHOMA. A STATE-OF-THE-ART REVIEW (1) Part 1- Epidemiology, pathogenesis, clinicopathologic characteristics, differential diagnosis, prognostic factors and special populations
3421PDF: 2324HTML: 1404 -
LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML
1594PDF: 1114HTML: 227 -
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN ADULT ACUTE LYMPHOBLASTIC LEUKEMIA: DIAGNOSTIC TOOLS, PROPHYLAXIS AND THERAPY
3941PDF: 1887HTML: 5190Table 1: 165 -
Guest Editor: Pellegrino Musto REFINING HIGH-RISK MULTIPLE MYELOMA: ADVANCEMENTS IN GENOMIC, CLINICAL, AND PROGNOSTIC CRITERIA Multiple Myeloma High Risk Classificatio
2063PDF: 1511HTML: 247 -
MODERN IMMUNOTHERAPY OF ADULT B-LINEAGE ACUTE LYMPHOBLASTIC LEUKEMIA WITH MONOCLONAL ANTIBODIES AND CHIMERIC ANTIGEN RECEPTOR MODIFIED T CELLS
2198PDF: 1288HTML: 17050Bassan Fig.1: 133Bassan Fig.2: 129Bassan Fig.4: 125Fig.3: 162 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
1952PDF: 1451HTML: 256 -
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION
1015PDF: 524HTML: 1670Figures: 140Fifures Sanz: 155tables Sanz: 163Untitled: 155 -
ARA-C, IDARUBICINE AND GENTUZUMAB OZOGAMICIN (AIM) AS SALVAGE TREATMENT IN ADVANCED ACUTE MYELOID LEUKEMIA PATIENTS
1640PDF: 776HTML: 921cover letter: 246 -
ClinicaI Reversible Myelopathy in T-Cell Lymphoblastic Lymphoma Treated with Nelarabine and Radiotherapy: Report of a Case and Review of Literature of an Increasing Complication
2313PDF: 958HTML: 1627Fig 1: 165Tab I: 190Cover Letter: 180 -
GASTROINTESTINAL MYELOID SARCOMA A CASE PRESENTATION AND CRITICAL REVIEW OF THE LITERATURE GASTROINTESTINAL MYELOID SARCOMA
1148PDF: 562HTML: 197 -
ASSESSMENT OF CONGENITAL NEUTROPENIA IN CHILDREN: COMMON CLINICAL SCENERIES AND CLUES FOR MANAGEMENT Assessment of congenital neutropenia in children
1848PDF: 1044HTML: 553 -
IMATINIB IN CHRONIC MYELOID LEUKEMIA: AN OVERVIEW
4505PDF: 2708HTML: 2223







